DOAJ Open Access 2026

The integration of artificial intelligence and biotechnology in medicine: accelerating novelty in biomarker-targeted discovery and drug delivery systems

Christopher Busayo Olowosoke Daniel Ogbonnaya Nwankwo Chinedu Shedrach Izu Prosper Obed Chukwuemeka

Abstrak

Artificial intelligence (AI) and biotechnology are two transformative fields converging to benefit STEM because of their reliance on data and models. The tools from both fields have redefined and improved translational performance of laboratory investigations on drug and biomarker-targeted discovery, drug design, drug development and drug delivery for personalized treatment. Although the long term merit of this integration of AI in biotechnology outweighs the demerit but is the current trend suitable and truly applicable for clinical intervention and therapy upgrades. In this article, we indicated how some key AI-biotech research is supporting accelerated novelty in biomarker-targeted discovery and drug delivery system (DDS) for disease management rather than merely incremental changes in 21st century.

Topik & Kata Kunci

Toxicology. Poisons Biotechnology Biology (General)

Penulis (4)

Christopher Busayo Olowosoke

Daniel Ogbonnaya Nwankwo

Chinedu Shedrach Izu

Prosper Obed Chukwuemeka

Format Sitasi

APA MLA BibTeX

Olowosoke, C.B., Nwankwo, D.O., Izu, C.S., Chukwuemeka, P.O. (2026). The integration of artificial intelligence and biotechnology in medicine: accelerating novelty in biomarker-targeted discovery and drug delivery systems. https://doi.org/10.1016/j.abst.2025.12.002

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →

Lihat di Sumber doi.org/10.1016/j.abst.2025.12.002

Informasi Jurnal

Tahun Terbit: 2026
Sumber Database: DOAJ
DOI: 10.1016/j.abst.2025.12.002
Akses: Open Access ✓